Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy

Hyperammonemia has been reported to be associated with patients who receive valproic acid (VPA) therapy. This study aimed to determine the risk factors for hyperammonemia in patients with epilepsy treated with VPA. One hundred and fifty-eight adult patients with epilepsy aged older than 17 years who...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Medicine (Baltimore)
Главные авторы: Tseng, Yu-Lung, Huang, Chi-Ren, Lin, Chih-Hsiang, Lu, Yan-Ting, Lu, Cheng-Hsien, Chen, Nai-Ching, Chang, Chiung-Chih, Chang, Wen-Neng, Chuang, Yao-Chung
Формат: Artigo
Язык:Inglês
Опубликовано: Wolters Kluwer Health 2014
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616274/
https://ncbi.nlm.nih.gov/pubmed/25192484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000066
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы